Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy—A Retrospective Bi-Centric Cohort Study

SIMPLE SUMMARY: Retrospective analyses suggest that men treated with immune-checkpoint inhibitor (ICI) monotherapy for non-small cell lung cancer (NSCLC) have better outcomes than women. However, female patients have more favorable responses when chemotherapy (CHT) is given together with ICI. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, David, Brauner, Anna, Huemer, Florian, Rinnerthaler, Gabriel, Horner, Andreas, Wass, Romana, Brehm, Elmar, Kaiser, Bernhard, Greil, Richard, Lamprecht, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750380/
https://www.ncbi.nlm.nih.gov/pubmed/35008255
http://dx.doi.org/10.3390/cancers14010093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750380/
https://www.ncbi.nlm.nih.gov/pubmed/35008255
http://dx.doi.org/10.3390/cancers14010093

Ejemplares similares